BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38711034)

  • 1. Tenascin C as a novel zinc finger protein 750 target regulating the immunogenicity via DNA damage in lung squamous cell carcinoma.
    Xia L; Lin H; Cao H; Lian J
    BMC Cancer; 2024 May; 24(1):561. PubMed ID: 38711034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma.
    Wang X; Huang Z; Li L; Wang G; Dong L; Li Q; Yuan J; Li Y
    BMC Cancer; 2022 Aug; 22(1):866. PubMed ID: 35941578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
    Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
    DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
    Xu F; Zhang H; Chen J; Lin L; Chen Y
    Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma.
    Sato T; Yoo S; Kong R; Sinha A; Chandramani-Shivalingappa P; Patel A; Fridrikh M; Nagano O; Masuko T; Beasley MB; Powell CA; Zhu J; Watanabe H
    Cancer Res; 2019 Dec; 79(24):6084-6100. PubMed ID: 31551362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation.
    Gao L; Guo YN; Zeng JH; Ma FC; Luo J; Zhu HW; Xia S; Wei KL; Chen G
    Int J Oncol; 2019 May; 54(5):1651-1664. PubMed ID: 30896821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analyses of a CD8
    Chen L; Weng Y; Cui X; Li Q; Peng M; Song Q
    BMC Bioinformatics; 2023 Jun; 24(1):238. PubMed ID: 37280525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients.
    Zhang T; Yang H; Sun B; Yao F
    Aging (Albany NY); 2021 Jan; 13(3):3819-3842. PubMed ID: 33428598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZNF750 inhibited the malignant progression of oral squamous cell carcinoma by regulating tumor vascular microenvironment.
    Pan L; Yang H; Xu C; Chen S; Meng Z; Li K; Chen H
    Biomed Pharmacother; 2018 Sep; 105():566-572. PubMed ID: 29890464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of downregulated ADARB1 in lung squamous cell carcinoma.
    Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z
    Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA HHIP-AS1 suppresses lung squamous cell carcinoma by stabilizing HHIP mRNA.
    Hu Z; Liu Y; Tang J; Luo R; Qin J; Mo Z; Xie J; Jiang X; Wei S; Lin C
    Life Sci; 2023 May; 321():121578. PubMed ID: 36958438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells.
    Zheng X; Zhang Y; Wu S; Jiang B; Liu Y
    Mol Biotechnol; 2022 Jul; 64(7):832-840. PubMed ID: 35150405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of RAD52 as a lung cancer susceptibility gene in the 12p13.33 locus.
    Lieberman R; Xiong D; James M; Han Y; Amos CI; Wang L; You M
    Mol Carcinog; 2016 May; 55(5):953-63. PubMed ID: 26013599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential
    Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells.
    Lu Y
    Comput Math Methods Med; 2021; 2021():6248793. PubMed ID: 34306176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma.
    Yang Z; Zhang C; Feng Y; Qi W; Cui Y; Xuan Y
    Exp Mol Pathol; 2019 Aug; 109():104239. PubMed ID: 30904401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma.
    Hazawa M; Lin DC; Handral H; Xu L; Chen Y; Jiang YY; Mayakonda A; Ding LW; Meng X; Sharma A; Samuel S; Movahednia MM; Wong RW; Yang H; Tong C; Koeffler HP
    Oncogene; 2017 Apr; 36(16):2243-2254. PubMed ID: 27819679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Function and mechanism of zinc finger protein ZNF50 in inhibiting the growth of esophageal squamous cell carcinoma cells].
    Wang J; Bi YH; Yang J; Liu F; Li YK; Cui HY; Wang F; Liu J; Yang B; Zhang L
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):7-12. PubMed ID: 28104026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.